期刊文献+

肝纤维化病因与机制研究进展 被引量:13

Progress in Etiology and Pathogenesis of Liver Fibrosis
下载PDF
导出
摘要 肝纤维化(hepatic fibrosis,HF)是由遗传相关疾病、慢性病毒性肝炎、酒精性肝炎、胆汁淤积和药物性肝损伤等多种慢性肝病引起的过度修复反应产生多种细胞外基质(extracellular matrix,ECM)的异常沉积的结果。肝纤维化的发生发展机制和肝星状细胞(hepatic stellate cells,HSC)、肝巨噬细胞、内质网应激(endoplasmic reticulum stress,ERs)和自噬等有关。肝脏的纤维化是一个动态发展过程,在没有干预的情况下会继续发展成为肝硬化,甚至发展为肝细胞癌。因此,延缓或者逆转肝纤维化的发生具有非常重要的临床意义。对肝纤维化病因和发生发展机制总结,为抗肝纤维化的药物研究提供参考。 Liver fibrosis(HF) is the result of abnormal deposition of various extracellular matrix(ECM) caused by the over-repair response of various chronic liver diseases,such as genetic-related diseases,chronic viral hepatitis,alcoholic hepatitis,cholestasis and drug-induced liver injury. The pathogenesis of hepatic fibrosis is related to hepatic stellate cell(HSC),hepatic macrophage,endoplasmic reticulum stress(ERs) and autophagy.Liver fibrosis is a dynamic process that can progress to cirrhosis or even hepatocellular carcinoma without intervention. Therefore,delaying or reversing the occurrence of liver fibrosis has very important clinical significance.The purpose of this review is to summarize the etiology,occurrence and development mechanism of liver fibrosis and provide a reference for the research of anti-liver fibrosis drugs.
作者 何迪 陈鹏 刘锋 徐杨 韩磊 丁文静 Di HE;Peng CHEN;Feng LIU;Yang XU;Lei HAN;Wenjing DING(Dept.of Hepatobiliary and Pancreatic Surgery,The 2nd Affiliated Hospital of Kunming Medical University,Kunming Yunnan 650101;Dept.of Clinical Medicine,Advanced School of Chinese Medicine in Baoshan,Baoshan Yunnan 678000,China)
出处 《昆明医科大学学报》 CAS 2022年第11期165-171,共7页 Journal of Kunming Medical University
基金 国家自然科学基金资助项目(81860124) 昆明医科大学研究生创新基金资助项目(2021S056)。
关键词 肝纤维化 病因 肝星状细胞 内质网应激 Liver fibrosis Etiology Hepatic stellate cell Endoplasmic reticulum stress
  • 相关文献

参考文献4

二级参考文献9

共引文献23

同被引文献168

引证文献13

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部